J Grøndahl-Hansen

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas.

Charles Pyke, Peter Kristensen, J Grøndahl-Hansen et al. · PubMed · 1991 · 438 citations

Medicine, Cell Biology, Oncology +10

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis.

J Grøndahl-Hansen, I. J. Christensen, Christian Rosenquist et al. · PubMed · 1993 · 390 citations

Medicine, Cancer Biology, Oncology +13

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue.

Helle Pedersen, Nils Brünner, Deanne Francis et al. · PubMed · 1994 · 290 citations

Medicine, Oncology, Cancer Immunology +14

Urokinase- and Tissue-Type Plasminogen Activators in Keratinocytes During Wound Reepithelialization In Vivo

J Grøndahl-Hansen, Leif R. Lund, Elisabeth Ralfkiær et al. · Journal of Investigative Dermatology · 1988 · 239 citations

Veterinary Medicine, Dermatology, Cell Signaling +12

Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.

P.A. Andreasen, Lene Nielsen, Peter Kristensen et al. · Journal of Biological Chemistry · 1986 · 228 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +11